RedHill Biopharma appeals Nasdaq delisting notice Oct 22, 2025 04:51PM
Cumberland Pharmaceuticals partners with RedHill for Talicia commercialization Oct 20, 2025 09:05AM
RedHill Biopharma (RDHL) Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties Feb 25, 2025 07:04AM